Data - the essential ingredient for driving innovation in food manufacturing

ARTICLE SUMMARY

The increasing availability of data provides opportunities for better decision making in the food manufacturing industry, playing a key role in minimizing waste, supply chain costs and inefficiencies in the production process, as well as forming the basis behind many new products and technical advancements.

authors
Related Services
Related Industries

The increasing availability of data provides opportunities for better decision making in the food manufacturing industry, playing a key role in minimizing waste, supply chain costs and inefficiencies in the production process, as well as forming the basis behind many new products and technical advancements.

Businesses in the sector (and beyond) are therefore seeking to capitalize on the boom in the ‘data economy’, with so-called ‘Big Data’ leading to, and being intrinsic in, innovations in food production.

Data-driven innovations are offering companies an all-important competitive advantage, with intellectual property rights being central to maximizing the value of the investment made.

This article, written exclusively for Food Manufacture explores the availability and role of IP in protecting data-driven innovations to be used by your business and covers the following:

  • What is Big Data?
  • How to protect your data-driven innovations
  • Maximising revenue through agreements and licensing arrangements
  • The importance of a tailor-made IP strategy

You can read the full article here.

Related News

Combination therapies: IP considerations for synergistic biologic products

Combination therapies: IP considerations for synergistic biologic products

Perfect storm – four drivers behind the mRNA litigation wave

Perfect storm – four drivers behind the mRNA litigation wave

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

See All News